Literature DB >> 21673726

Mechanotransduction: YAP and TAZ feel the force.

Katharine H Wrighton.   

Abstract

Entities:  

Year:  2011        PMID： 21673726     DOI： 10.1038/nrm3136

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN： 1471-0072            Impact factor:   94.444


× No keyword cloud information.
  1 in total

1.  Role of YAP/TAZ in mechanotransduction.

Authors:  Sirio Dupont; Leonardo Morsut; Mariaceleste Aragona; Elena Enzo; Stefano Giulitti; Michelangelo Cordenonsi; Francesca Zanconato; Jimmy Le Digabel; Mattia Forcato; Silvio Bicciato; Nicola Elvassore; Stefano Piccolo
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962
  1 in total
  11 in total

1.  Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer.

Authors:  Anne Serrao; Laura M Jenkins; Alexander A Chumanevich; Ben Horst; Jiaxin Liang; Michael L Gatza; Nam Y Lee; Igor B Roninson; Eugenia V Broude; Karthikeyan Mythreye
Journal:  Oncogene       Date:  2018-05-21       Impact factor: 9.867

Review 2.  The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

Authors:  Wanjin Hong; Kun-Liang Guan
Journal:  Semin Cell Dev Biol       Date:  2012-05-29       Impact factor: 7.727

3.  Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model.

Authors:  Zeyu Yang; Kentaro Nakagawa; Aradhan Sarkar; Junichi Maruyama; Hiroaki Iwasa; Yijun Bao; Mari Ishigami-Yuasa; Shigeru Ito; Hiroyuki Kagechika; Shoji Hata; Hiroshi Nishina; Shinya Abe; Masanobu Kitagawa; Yutaka Hata
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

4.  Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.

Authors:  I Acerbi; L Cassereau; I Dean; Q Shi; A Au; C Park; Y Y Chen; J Liphardt; E S Hwang; V M Weaver
Journal:  Integr Biol (Camb)       Date:  2015-05-11       Impact factor: 2.192

Review 5.  Tumour suppressor genes in chemotherapeutic drug response.

Authors:  Dulcie Lai; Stacy Visser-Grieve; Xiaolong Yang
Journal:  Biosci Rep       Date:  2012-08       Impact factor: 3.840

6.  RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer.

Authors:  S E Lee; J U Lee; M H Lee; M J Ryu; S J Kim; Y K Kim; M J Choi; K S Kim; J M Kim; J W Kim; Y W Koh; D-S Lim; Y S Jo; M Shong
Journal:  Oncogenesis       Date:  2013-07-15       Impact factor: 7.485

Review 7.  Regulation of Hippo signaling by actin remodeling.

Authors:  Jimyung Seo; Joon Kim
Journal:  BMB Rep       Date:  2018-03       Impact factor: 4.778

8.  Role of Hippo Pathway Effector Tafazzin Protein in Maintaining Stemness of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC).

Authors:  Madhumala Gopinath; Rosa Di Liddo; Francesco Marotta; Ramachandran Murugesan; Antara Banerjee; Sushmitha Sriramulu; Ganesan Jothimani; Vimala Devi Subramaniam; Srinivasan Narasimhan; Swarna Priya K; Xiao-Feng Sun; Surajit Pathak
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2018-04-01

9.  The Hippo network kinase STK38 contributes to protein homeostasis by inhibiting BAG3-mediated autophagy.

Authors:  Christina Klimek; Ricarda Jahnke; Judith Wördehoff; Barbara Kathage; Daniela Stadel; Christian Behrends; Alexander Hergovich; Jörg Höhfeld
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-07-19       Impact factor: 4.739

10.  Retinal blood vessel-origin yes-associated protein (YAP) governs astrocytic maturation via leukaemia inhibitory factor (LIF).

Authors:  Li-Qian-Yu Ai; Rong-Di Yuan; Xi Chen; Yun-Jia Liu; Wen-Yi Liu; Jing-Yi Zhu; Zhou Zhang; Jun Yan; Chun-Lin Chen; Sen Lin; Jian Ye
Journal:  Cell Prolif       Date:  2020-01-08       Impact factor: 6.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.